Financial Wealth Daily

JPMorgan beats profit estimates on investment banking boost

By Niket Nishant and Nupur Anand (Reuters) – JPMorgan Chase beat estimates for second-quarter profit on Friday, as its investment banking business benefited from a resurgence in dealmaking and strong capital market activity. More companies are tapping capital markets to raise funds and striking takeover deals as they become confident in the U.S. economy’s ability…

Read More

US FTC to delay decision on Chevron-Hess deal during Exxon arbitration, Bloomberg reports

(Reuters) – The U.S. Federal Trade Commission plans to delay its decision whether to block Chevron’s $53 billion takeover of Hess until after an arbitration case with Exxon Mobil is settled, Bloomberg News reported on Thursday. The signal from the U.S. regulator is another hurdle for Chevron’s proposed acquisition of Hess. The deal, which was…

Read More

Ukraine gets new $225 million US military aid after Biden meets Zelenskiy

By Jeff Mason and Kanishka Singh WASHINGTON (Reuters) -The United States on Thursday announced a new security package for Ukraine worth $225 million, which includes a Patriot missile battery, additional ammunition for high-mobility artillery rocket systems and missiles, among other items. WHY IT’S IMPORTANT Washington, Ukraine’s biggest supporter, has provided more than $50 billion in…

Read More

Boeing CEO called NTSB chair to apologize after MAX probe rules violation

By David Shepardson WASHINGTON (Reuters) -Boeing CEO Dave Calhoun apologized and vowed the planemaker would follow government rules after the National Transportation Safety Board said the company provided non-public information speculating about possible causes on a 737 MAX mid-air emergency, the safety panel’s top official said on Wednesday. NTSB Chair Jennifer Homendy told Reuters Calhoun…

Read More

US FTC to sue drug middlemen over insulin prices, WSJ reports

(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health – the three largest pharmacy-benefit managers – over their tactics for negotiating prices for drugs including insulin, the Wall Street Journal reported on Wednesday. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate fees and…

Read More